Showing results (31-40 of 120) with videos related to

Sort By:
Pageof 12
Journal of Translational Medicine|March 11, 2011
Glutamate carboxypeptidase activity in human skin biopsies as a pharmacodynamic marker for clinical studiesCamilo Rojas, Marigo Stathis, Michael Polydefkis, et al.
Cadernos De Saude Publica|August 28, 2024
[Nine-year trend in Escherichia coli resistance to ciprofloxacin: cross-sectional study in a hospital in Colombia]Emy Shilena Torres Villalobos, José Alberto Mendivil De la Ossa, Yolima Pertuz Meza, et al.
Molecular and Cellular Neurosciences|March 28, 2018
Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disordersMurat Kilinc, Thomas Creson, Camilo Rojas, et al.
Journal of Medicinal Chemistry|May 30, 2008
Synthesis and biological evaluation of D-amino acid oxidase inhibitorsDana Ferraris, Bridget Duvall, Yao-Sen Ko, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 24, 2013
Bioanalytical method for evaluating the pharmacokinetics of the GCP-II inhibitor 2-phosphonomethyl pentanedioic acid (2-PMPA)Rana Rais, Camilo Rojas, Krystyna Wozniak, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 6, 2012
Reversible disulfide formation of the glutamate carboxypeptidase II inhibitor E2072 results in prolonged systemic exposures in vivoRana Rais, Randall Hoover, Krystyna Wozniak, et al.
Journal of Neuroscience Research|August 19, 2014
Mutant disrupted-in-schizophrenia 1 in astrocytes: focus on glutamate metabolismSofya Abazyan, Eun Ju Yang, Bagrat Abazyan, et al.
Advances in Experimental Medicine and Biology|June 29, 2006
Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategyAjit G Thomas, Krystyna M Wozniak, Takashi Tsukamoto, et al.
Journal of Affective Disorders|April 12, 2026
Depression and anxiety in adults with epilepsy. Systematic literature review and meta-analysisJuan Camilo Rojas-López, Suhamny Navas-Peñaranda, Mateo Avilés-Gómez, et al.
Pageof 12